Cargando…

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer

SIMPLE SUMMARY: The mutational status of certain genes can be useful to advance therapeutic decision making and clinical management of cancer patients. In metastatic colorectal cancer, current clinicopathological factors employed in clinical practice have low or modest individual effect on survival,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahoz, Sara, Rodríguez, Adela, Fernández, Laia, Gorría, Teresa, Moreno, Reinaldo, Esposito, Francis, Oliveres, Helena, Albiol, Santiago, Saurí, Tamara, Pesantez, David, Riu, Gisela, Cuatrecasas, Miriam, Jares, Pedro, Pedrosa, Leire, Pineda, Estela, Postigo, Antonio, Castells, Antoni, Prat, Aleix, Maurel, Joan, Camps, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735648/ https://www.ncbi.nlm.nih.gov/pubmed/36497403 http://dx.doi.org/10.3390/cancers14235921

Ejemplares similares

A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes
por: Pedrosa, Leire, et al.
Publicado: (2022)

Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients
por: Oliveres, Helena, et al.
Publicado: (2021)

The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
por: Sánchez-Tilló, Ester, et al.
Publicado: (2023)

Prognostic Significance of NOTCH1 and FBXW7 Mutations in Pediatric T-ALL
por: Erbilgin, Yucel, et al.
Publicado: (2010)

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
por: Rodriguez, Adela, et al.
Publicado: (2021)

Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers
por: Liu, Yiping, et al.
Publicado: (2023)

Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage—A Multicentre Study
por: Diaz-Mercedes, Sherley, et al.
Publicado: (2022)

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
por: Korphaisarn, Krittiya, et al.
Publicado: (2017)

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
por: Español-Rego, Marta, et al.
Publicado: (2022)

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors
por: Jardim, Denis L., et al.
Publicado: (2014)

FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development
por: Davis, Hayley, et al.
Publicado: (2011)

FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
por: Li, Ningning, et al.
Publicado: (2015)

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
por: Codony-Servat, Jordi, et al.
Publicado: (2017)

The Tumor Microenvironment in Colorectal Cancer Therapy
por: Pedrosa, Leire, et al.
Publicado: (2019)

Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia
por: Liu, Rong-Bin, et al.
Publicado: (2017)

High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer
por: Korphaisarn, Krittiya, et al.
Publicado: (2019)

Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation
por: Meyer, Alison E., et al.
Publicado: (2020)

Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience
por: Lovisa, Federica, et al.
Publicado: (2021)

The Role of FBXW7 in Gynecologic Malignancies
por: Di Fiore, Riccardo, et al.
Publicado: (2023)

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status
por: Prat, Aleix, et al.
Publicado: (2014)

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
por: Griguolo, Gaia, et al.
Publicado: (2020)

Establishment and analysis of a novel mouse line carrying a conditional knockin allele of a cancer-specific FBXW7 mutation
por: Ikenoue, Tsuneo, et al.
Publicado: (2018)

Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
por: Zheng, Yang, et al.
Publicado: (2020)

Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis
por: Shang, Wei, et al.
Publicado: (2021)

Different miRNAs Related to FBXW7 Mutations or High Mitotic Indices Contribute to Rectal Neuroendocrine Tumors: A Pilot Study
por: Kang, Ho Suk, et al.
Publicado: (2023)

Copy‐number intratumor heterogeneity increases the risk of relapse in chemotherapy‐naive stage II colon cancer
por: Lahoz, Sara, et al.
Publicado: (2022)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
por: Martínez-Sáez, Olga, et al.
Publicado: (2020)

MYC is a critical target of FBXW7
por: Sato, Mai, et al.
Publicado: (2014)

A widely used pan-isoform-FBXW7 antibody used in cell cycle studies does not detect FBXW7
por: Ennis, Hannah, et al.
Publicado: (2023)

Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
por: Davis, Hayley, et al.
Publicado: (2014)

Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology
por: Pedrosa, L., et al.
Publicado: (2023)

Loss of CDC4/FBXW7 in Gastric Carinoma
por: Milne, A. N., et al.
Publicado: (2010)

Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
por: Diaz-Mercedes, Sherley, et al.
Publicado: (2019)

The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial
por: Else, Monica, et al.
Publicado: (2021)

Both Ubiquitin Ligases FBXW8 and PARK2 Are Sequestrated into Insolubility by ATXN2 PolyQ Expansions, but Only FBXW8 Expression Is Dysregulated
por: Halbach, Melanie Vanessa, et al.
Publicado: (2015)

The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor
por: Xu, Jie, et al.
Publicado: (2017)

Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis
por: Chen, Xin, et al.
Publicado: (2020)

Fbxw7 Controls Angiogenesis by Regulating Endothelial Notch Activity
por: Izumi, Nanae, et al.
Publicado: (2012)

Regulation of GSK3β-FBXW7-JUNB Axis
por: Pérez-Benavente, Beatriz, et al.
Publicado: (2013)

FBXW7: a critical tumor suppressor of human cancers
por: Yeh, Chien-Hung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rl65ke0p95qqn2aersin3o8dt